BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 26, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Ziopharm Finding Ways To Optimize Arsenic In Cancer

Sep. 16, 2004

New NCI Initiative Aims To Focus Nanotechnology's Cancer Power

Sep. 16, 2004
By Anette Breindl

GenData Out-Licenses Database To Celera For Autoimmune Work

Sep. 16, 2004
By Aaron Lorenzo
GenData Research Corp. agreed to provide genetic data to Celera Diagnostics for use in the latter's autoimmune disease research. (BioWorld Today)
Read More

Other News To Note

Sep. 16, 2004

Scientists Grow Stem Cell Line With Cystic Fibrosis Mutation

Sep. 15, 2004
By Nuala Moran

Newron Moving Safinamide Into Parkinson's Pivotal Trial

Sep. 15, 2004
By Cormac Sheridan

Karo Bio Seeking SEK96M, Cutting 20 R&D Employees

Sep. 15, 2004
By Cormac Sheridan
Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)
Read More

YM Funding Gets Up To C$23M For Tesmilifene Phase III Trials

Sep. 15, 2004
As its Phase III tesmilifene trial continues to enroll breast cancer patients, YM BioSciences Inc. entered a bought-deal agreement that could result in gross proceeds for the company of C$23 million (US$17.8 million). (BioWorld Today)
Read More

Other News To Note

Sep. 15, 2004

FDA's Decision On Omnitrope Points To Biogeneric Haziness

Sep. 15, 2004
By Nuala Moran
Previous 1 2 … 7354 7355 7356 7357 7358 7359 7360 7361 7362 … 10255 10256 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Cell nucleus architecture

    4D Nucleome opens new wave of gene regulation research, discovery

    BioWorld
    After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
  • Drug capsule spilling onto brain

    Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s

    BioWorld Science
    Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
  • Business pipeline illustration

    Transcripta Bio raises funding to advance neuro pipeline

    BioWorld Science
    Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
  • Other news to note for July 22, 2026

    BioWorld
    Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing